Correlation between glycemic control and cardio-metabolic risk factors in type 2 diabetes patients: Cross-sectional experimental study
BACKGROUNDType 2 diabetes mellitus (T2DM) is associated with disturbances in glucose regulation and lipid metabolism, which may contribute to an increased risk of cardiometabolic complications.However, evidence describing the relationship between glycemic indicators and lipid parameters among patients with T2DM in Yemen remains limited. AIMTo examine the observational associations between glycemic indicators and lipid profile parameters among adults with T2DM attending routine laboratory assessment in Sana'a, Yemen. METHODSA laboratory-based cross-sectional study was conducted at the National Center of Public Health Laboratories in Sana'a, Yemen, from January to July 2022.A total of 145 adults with T2DM were included using convenience sampling.Glycemic indicators and lipid profile parameters were assessed using routine laboratory measurements.Descriptive statistics, Pearson's correlation, and multiple logistic regression were used in data analysis. RESULTST2DM patients aged from 20 years to 80 years, with an average age of 54.35 ± 8.02 years.82 males (56.6%) and 63 females (43.4%) were grouped in gender.The majority of subjects (72.4%) were not at diabetic dyslipidemia risk, while 27.6% were counted at risk.Body mass index (BMI), fasting blood sugar (FBS), and glycated hemoglobin (HbA1c) mean values were 2.82 ± 0.962 kg/m 2 , 1.37 ± 0.489, and 1.67 ± 0.474, respectively.Statistically, a positive association was observed between HbA1c and FBS with BMI, total cholesterol (TC), triglyceride (TG), and low-density 4 / 29 lipoprotein cholesterol (LDL-C), while negative correlations were found with highdensity lipoprotein cholesterol (HDL-C).Diabetic patients with poor glycemic control (HbA1c ≥ 6.0) had shown higher TC, TG, LDL-C, and HDL-C in comparison with subjects had good glycemic control (HbA1c < 6.0). CONCLUSIONThe findings suggest an association between HbA1c levels and lipid parameters in patients with T2DM.HbA1c may provide complementary information when assessing glycemic control and cardiometabolic risk; however, further studies are needed to confirm these associations and determine whether HbA1c can help identify patients at increased risk of dyslipidemia.Assessment of lipid profiles remains important for identifying dyslipidemia and clinical management.
Authors
- Lutfi Al-Maktari
- Mariam Shakeebd
- Noora Al-khaldid
Institutions
- Sana'a University (YE)
Publication Details
- Journal
- World Journal of Experimental Medicine
- Published
- 2026-11-16
- DOI
- https://doi.org/10.5493/wjem.118234
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 0.00